You are here
CERID Bibliography
.
Immunology in the Clinic Review Series; focus on host responses: T cell responses to herpes simplex viruses. Clin Exp Immunol. 2012 ;167(1):47-58.
. Macaque homologs of EBV and KSHV show uniquely different associations with simian AIDS-related lymphomas. PLoS Pathog. 2012 ;8(10):e1002962.
. Improved innate and adaptive immunostimulation by genetically modified HIV-1 protein expressing NYVAC vectors. PLoS One. 2011 ;6(2):e16819.
Safety and immunogenicity of long HSV-2 peptides complexed with rhHsc70 in HSV-2 seropositive persons. Vaccine. 2011 ;29(47):8520-9.
. Reduction of herpes simplex virus type-2 replication in cell cultures and in rodent models with peptide-conjugated morpholino oligomers. Antivir Ther. 2010 ;15(8):1141-9.
. Intracellular innate immune cascades and interferon defenses that control hepatitis C virus. J Interferon Cytokine Res. 2009 ;29(9):489-98.
. . Antiviral potency analysis and functional comparison of consensus interferon, interferon-alpha2a and pegylated interferon-alpha2b against hepatitis C virus infection. Antivir Ther. 2008 ;13(7):851-62.
. An extremely diverse CD4 response to vaccinia virus in humans is revealed by proteome-wide T-cell profiling. J Virol. 2008 ;82(14):7120-34.
Unveiling viral enablers. Nat Biotechnol. 2008 ;26(10):1093-4.
. Fas (CD95) induces macrophage proinflammatory chemokine production via a MyD88-dependent, caspase-independent pathway. J Leukoc Biol. 2007 ;82(3):721-8.
. Ebola virus VP35 protein binds double-stranded RNA and inhibits alpha/beta interferon production induced by RIG-I signaling. J Virol. 2006 ;80(11):5168-78.
. Sequence-based methods for identifying epidemiologically linked herpes simplex virus type 2 strains. J Clin Microbiol. 2006 ;44(7):2541-6.
. .
Disruption of hepatitis C virus RNA replication through inhibition of host protein geranylgeranylation. Proc Natl Acad Sci U S A. 2003 ;100(26):15865-70.
. .
Molecular mechanisms of interferon resistance mediated by viral-directed inhibition of PKR, the interferon-induced protein kinase. Pharmacol Ther. 1998 ;78(1):29-46.
. . .
.
Cellular and viral ligands that interact with the EGF receptor. Semin Cancer Biol. 1990 ;1(4):257-63.
. Characterization of the surface proteins of SV40-transformed mouse and human cells: absence of SV40-specific proteins. Int J Cancer. 1983 ;31(5):639-48.
.